Portola Capital Partners Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 2
  • Investments
  • 2
  • Exits
  • 2

Portola Capital Partners General Information


Portola Capital Partners is a healthcare investment and advisory firm that focuses on innovation, growth and cross-border deals in North America, Asia, Europe and emerging markets. The firm also focuses on investing in emerging public and private biotechnology and device companies.

Contact Information

Year Founded
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • 450 Lexington Avenue
  • Suite 39B
  • New York, NY 10017
  • United States

Portola Capital Partners Investments (2)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Aptinyx 15-Sep-2015 Seed Round Drug Discovery Generating Revenue/Not Profitable
000000 02-Dec-2014 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3
To view Portola Capital Partners’s complete investments history, request access »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Portola Capital Partners Exits (2)

Company Name Exit Date Exit Type Exit Size
Aptinyx 21-Jun-2018 IPO 00000
000000 28-Aug-2015 000000000000000000 00.000
To view Portola Capital Partners’s complete exits history, request access »

Portola Capital Partners Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Portola Capital Partners Team (1)

Name Title Deals Funds Boards Office
Sasha Blaug Ph.D Senior Investment Analyst & Vice President New York, NY
To view Portola Capital Partners’s complete team members history, request access »